You are in: eMedicine Specialties > Obstetrics and Gynecology > General Obstetrics EndometritisArticle Last Updated: Aug 15, 2007AUTHOR AND EDITOR INFORMATIONAuthor: Gema T Simmons, MD, Consulting Staff, Department of Obstetrics and Gynecology, Alegent Health Gema T Simmons is a member of the following medical societies: American College of Obstetricians and Gynecologists Editors: Anthony Charles Sciscione, DO, Director, Division of Maternal-Fetal Medicine, Professor, Department of Obstetrics and Gynecology, Drexel University College of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Antonio V Sison, MD, FACOG, Program Director, Department of Obstetrics and Gynecology, Robert Wood Johnson University Hospital; Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Assumption Community Hospital; Michel E Rivlin, MD, Associate Professor, Coordinator, Quality Assurance/Quality Improvement, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine Author and Editor Disclosure Synonyms and related keywords: metritis, endomyometritis, endomyoparametritis, myometritis, Cesarean delivery, C section, pelvic inflammatory disease, PID, retained products of conception, obstetric endometritis, nonobstetric endometritis, salpingitis, Ureaplasma urealyticum, Peptostreptococcus, Gardnerella vaginalis, Bacteroides bivius, group B Streptococcus, Chlamydia, Enterococcus, cesarean delivery, bacterial vaginosis INTRODUCTIONBackgroundEndometritis is an infection of the endometrium or decidua, with extension into the myometrium and parametrial tissues. Endometritis is divided into obstetric and nonobstetric endometritis. It is the most common cause of fever during the postpartum period. Pelvic inflammatory disease (PID) is a common predecessor in the nonobstetric population. PathophysiologyEndometritis is infection of the endometrium or decidua, with extension into the myometrium and parametrial tissues. Endometritis usually results from an ascending infection from the lower genital tract. From a pathologic perspective, endometritis can be classified as acute versus chronic. Acute endometritis is characterized by the presence of neutrophils within the endometrial glands. Chronic endometritis is characterized by the presence of plasma cells and lymphocytes within the endometrial stroma. In the nonobstetric population, PID and invasive gynecologic procedures are the most common precursors to acute endometritis. In the obstetric population, postpartum infection is the most common predecessor. Chronic endometritis in the obstetric population is usually associated with retained products of conception after delivery or elective abortion. In the nonobstetric population, chronic endometritis has been seen with infections, such as chlamydia, tuberculosis, and bacterial vaginosis, and the presence of an intrauterine device. FrequencyUnited StatesIncidence varies depending on the route of delivery and the patient population. After a vaginal delivery, incidence is 1-3%. Following cesarean delivery, incidence ranges from 13-90%, depending on the risk factors present and whether perioperative antibiotic prophylaxis had been given. Mortality/Morbidity
AgeThis disorder affects females of reproductive age. CLINICALHistoryDiagnosis usually is based on clinical findings.
Physical
Causes
DIFFERENTIALSAppendicitis Pelvic Inflammatory Disease
|
| Drug Name | Clindamycin (Cleocin) |
|---|---|
| Description | Used in combination with gentamicin. Lincosamide useful as a treatment against serious skin and soft tissue infections caused by most staphylococci strains. Also effective against aerobic and anaerobic streptococci, except enterococci. Inhibits bacterial protein synthesis by inhibiting peptide chain initiation at bacterial ribosome where preferentially binds to the 50S ribosomal subunit, causing bacterial growth inhibition. |
| Adult Dose | 900 mg IV q8h |
| Pediatric Dose | 20-40 mg/kg/d IV divided q6-8h |
| Contraindications | Documented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis |
| Interactions | Increases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects; antidiarrheals may delay absorption |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis by allowing overgrowth of Clostridium difficile American Academy of Pediatrics states that clindamycin is compatible with breastfeeding |
| Drug Name | Gentamicin (Gentacidin, Garamycin) |
|---|---|
| Description | Aminoglycoside antibiotic used for gram-negative bacterial coverage. Used in combination with either clindamycin or in combination with metronidazole and ampicillin. Dosing regimens are numerous and are adjusted based on creatinine clearance and changes in the volume of distribution. Dose may be given IV or IM. |
| Adult Dose | 1.5 mg/kg IV q8h |
| Pediatric Dose | 2-2.5 mg/kg/d IV q8h |
| Contraindications | Documented hypersensitivity; non-dialysis-dependent renal insufficiency |
| Interactions | Coadministration with other aminoglycosides, cephalosporins, penicillins, and amphotericin B may increase nephrotoxicity; aminoglycosides enhance effects of neuromuscular blocking agents, thus prolonged respiratory depression may occur Coadministration with loop diuretics may increase auditory toxicity of aminoglycosides; possible irreversible hearing loss of varying degrees may occur (monitor regularly) |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studies in humans; may use if benefits outweigh risk to fetus |
| Precautions | Narrow therapeutic index (not intended for long-term therapy); caution in renal failure (not on dialysis), myasthenia gravis, hypocalcemia, and conditions that depress neuromuscular transmission; adjust dose in renal impairment; data are lacking concerning use while breastfeeding |
| Drug Name | Ampicillin (Omnipen, Marcillin) |
|---|---|
| Description | Used in combination with gentamicin and metronidazole. Interferes with bacterial cell-wall synthesis during active multiplication, causing bactericidal activity against susceptible organisms. |
| Adult Dose | 2 g IV q6h |
| Pediatric Dose | 50-200 mg/kg/d IV divided qid |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid and disulfiram elevate levels; allopurinol decreases effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction |
| Drug Name | Metronidazole (Flagyl) |
|---|---|
| Description | Used in combination with gentamicin and ampicillin. Imidazole ring-based antibiotic active against various anaerobic bacteria and protozoa. Appears to be absorbed into the cells and the intermediate-metabolized compounds that are formed bind DNA and inhibit protein synthesis, causing cell death. |
| Adult Dose | 500 mg IV q6h |
| Pediatric Dose | 15-30 mg/kg/d IV divided bid/tid |
| Contraindications | Documented hypersensitivity |
| Interactions | May increase toxicity of anticoagulants, lithium, and phenytoin; cimetidine may increase toxicity; disulfiram reaction may occur with orally ingested ethanol |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in hepatic disease; monitor for seizures and development of peripheral neuropathy American Academy of Pediatrics states that metronidazole should be used with caution while breastfeeding |
| Drug Name | Ampicillin/sulbactam sodium (Unasyn) |
|---|---|
| Description | Has been found to be efficacious as monotherapy in 80-90% of patients. Drug combination that uses a beta-lactamase inhibitor with ampicillin. Covers skin, enteric flora, and anaerobes. Not ideal for nosocomial pathogens. |
| Adult Dose | 3 g IV q6h |
| Pediatric Dose | 1.5-3 g IV q8h |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction; compatible with breastfeeding |
| Drug Name | Doxycycline (Bio-Tab, Doryx, Vibramycin) |
|---|---|
| Description | Used if Chlamydia is the cause of the endometritis. Inhibits protein synthesis and thus bacterial growth by binding with the 30S and possibly the 50S ribosomal subunits of susceptible bacteria. |
| Adult Dose | 100 mg PO/IV q12h |
| Pediatric Dose | <8 years: Not recommended >8 years: 1-2 mg/lb PO/IV q12h |
| Contraindications | Documented hypersensitivity; severe hepatic dysfunction |
| Interactions | Bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; tetracyclines can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy |
| Pregnancy | D - Unsafe in pregnancy |
| Precautions | Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last one-half of pregnancy through 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines American Academy of Pediatrics states that doxycycline is compatible with breastfeeding |
| Drug Name | Ertapenem (Invanz) |
|---|---|
| Description | Bactericidal activity results from inhibition of cell wall synthesis and is mediated through ertapenem binding to penicillin binding proteins. Stable against hydrolysis by a variety of beta-lactamases including penicillinases, cephalosporinases, and extended spectrum beta-lactamases. Hydrolyzed by metallo-beta-lactamases. |
| Adult Dose | 1 g qd for 14 d if given IV and 7 d if given IM; infuse over 30 min if given IV |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity to drug or amide-type anesthetics |
| Interactions | Probenecid may reduce renal clearance of ertapenem and increase half-life but benefit is minimum and does not justify coadministration |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Pseudomembranous colitis may occur; seizures and CNS adverse reactions may occur; when using with lidocaine to administer intramuscularly, avoid inadvertent injection into blood vessel |
Current research is evaluating the timing of administration of cephalosporin prior to skin incision versus at cord clamp for prevention of postcesarean infectious morbidity.
Another topic of research is the preoperative use of povidone-iodine vaginal preparation prior to cesarean delivery.
Article Last Updated: Aug 15, 2007